MESNA

Indications and dose

Urothelial toxicity following oxazaphosphorine therapy

By intravenous injection, or by continuous intravenous infusion

  • Child

    (consult local protocol).

Mucolytic in cystic fibrosi...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×